MedTrace Logo

Mindfulness Meditation and Insomnia in Alzheimer Disease Caregivers

NCT03538574 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 139

Last updated 2022-10-04

No results posted yet for this study

Summary

Treatment of insomnia in caregivers is needed given that 60% of Alzheimer disease caregivers report sleep complaints, and insomnia may add to the burden of AD caregiving and contribute to morbidity and mortality risk. This is the first intervention trial in AD caregivers to target insomnia and also evaluate two mechanisms of chronic disease risk, inflammation and cellular aging

Conditions

  • Insomnia Chronic

Interventions

BEHAVIORAL

CBT-I

CBT-I is a behavioral treatment for insomnia

BEHAVIORAL

MAP-I

MAP-I is a mindfulness meditation treatment for insomnia

Sponsors & Collaborators

Principal Investigators

  • Michael R Irwin, M.D. · University of California, Los Angeles

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-01
Primary Completion
2022-09-01
Completion
2022-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03538574 on ClinicalTrials.gov